Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Highlights
The price to earnings (P/E) is 15% lower than the 5-year quarterly average of 33.2 and 6% lower than the last 4 quarters average of 29.9
MDT's debt is down by 3% since the previous quarter and by 2.1% year-on-year
The net income has contracted by 10% from the previous quarter but it has grown by 3.4% YoY
The EPS has declined by 10% since the previous quarter but it rose by 3.8% year-on-year
Medtronic's quick ratio has decreased by 27% from the previous quarter and by 21% YoY
MDT's gross profit is down by 9% since the previous quarter and by 9% year-on-year
Key stats
What are the main financial stats of MDT
Market
Shares outstanding
1.34B
Market cap
$135.1B
Enterprise value
$155.75B
Valuations
Price to earnings (P/E)
28.21
Price to book (P/B)
2.66
Price to sales (P/S)
4.67
EV/EBIT
30.36
EV/EBITDA
19.99
EV/Sales
5.39
Earnings
Revenue
$28.91B
EBIT
$5.13B
EBITDA
$7.79B
Free cash flow
$6.02B
Per share
EPS
$3.57
Free cash flow per share
$4.49
Book value per share
$37.86
Revenue per share
$21.57
TBVPS
$23.71
Balance sheet
Total assets
$90.69B
Total liabilities
$39.82B
Debt
$24.8B
Equity
$50.74B
Working capital
$11.67B
Liquidity
Debt to equity
0.49
Current ratio
2.13
Quick ratio
1.5
Net debt/EBITDA
2.65
Margins
EBITDA margin
27%
Gross margin
67.4%
Net margin
16.6%
Operating margin
16.6%
Efficiency
Return on assets
5.2%
Return on equity
9.4%
Return on invested capital
11.6%
Return on capital employed
6.4%
Return on sales
17.7%
Dividend
Dividend yield
2.18%
DPS
$2.2
Payout ratio
61.6%
MDT stock price
How has the Medtronic stock price performed over time
Financial performance
How have Medtronic's revenue and profit performed over time
Revenue
$28.91B
Gross profit
$19.49B
Operating income
$4.79B
Net income
$4.79B
Gross margin
67.4%
Net margin
16.6%
The operating income has decreased by 25% QoQ and by 24% YoY
The operating margin has declined by 20% since the previous quarter and by 19% year-on-year
The net income has contracted by 10% from the previous quarter but it has grown by 3.4% YoY
MDT's net margin is up by 9% year-on-year but it is down by 2.9% since the previous quarter
Valuation
What is Medtronic stock price valuation
P/E
28.21
P/B
2.66
P/S
4.67
EV/EBIT
30.36
EV/EBITDA
19.99
EV/Sales
5.39
The price to earnings (P/E) is 15% lower than the 5-year quarterly average of 33.2 and 6% lower than the last 4 quarters average of 29.9
The EPS has declined by 10% since the previous quarter but it rose by 3.8% year-on-year
The stock's price to book (P/B) is 11% more than its 5-year quarterly average of 2.4 but 5% less than its last 4 quarters average of 2.8
The company's equity fell by 2.1% QoQ
MDT's P/S is 17% higher than its 5-year quarterly average of 4.0
Medtronic's revenue has decreased by 7% from the previous quarter and by 5% YoY
Efficiency
How efficient is Medtronic business performance
The company's return on invested capital fell by 28% YoY and by 24% QoQ
The return on sales has declined by 19% since the previous quarter and by 18% year-on-year
Medtronic's return on equity has decreased by 11% QoQ
MDT's return on assets is down by 10% since the previous quarter
Dividends
What is MDT's dividend history
DPS
$2.2
Dividend yield
2.18%
Payout ratio
61.6%
Recent dividends
Financial health
How did Medtronic financials performed over time
The total assets is 128% greater than the total liabilities
Medtronic's quick ratio has decreased by 27% from the previous quarter and by 21% YoY
The company's current ratio fell by 23% QoQ and by 18% YoY
MDT's debt is 51% smaller than its equity
MDT's debt is down by 3% since the previous quarter and by 2.1% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated
quarterly, unless otherwise specified.